Two children with hypophosphatasia with a heterozygous c.1559delT variant in the ALPL gene, the most common variant in Japanese populations
Hypophosphatasia (HPP), a genetic disorder characterized by decreased tissue-nonspecific alkaline phosphatase (TNSALP) activity, is caused by loss-of-function mutations in the ALPL gene, which encodes TNSALP. The most frequent pathogenic variant in Japanese patients with HPP is a frameshift mutation...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Bone Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352187222004600 |
| _version_ | 1811293798823624704 |
|---|---|
| author | Hiroshi Kitoh Masako Izawa Hiroshi Kaneko Akiko Kitamura Saori Matsuyama Kohji Kato Tomoo Ogi |
| author_facet | Hiroshi Kitoh Masako Izawa Hiroshi Kaneko Akiko Kitamura Saori Matsuyama Kohji Kato Tomoo Ogi |
| author_sort | Hiroshi Kitoh |
| collection | DOAJ |
| description | Hypophosphatasia (HPP), a genetic disorder characterized by decreased tissue-nonspecific alkaline phosphatase (TNSALP) activity, is caused by loss-of-function mutations in the ALPL gene, which encodes TNSALP. The most frequent pathogenic variant in Japanese patients with HPP is a frameshift mutation in the ALPL gene, c.1559delT, and its carrier frequency is reported to be one in 480 in the Japanese population. We report the cases of two Japanese children with HPP who had a heterozygous c.1559delT variant in the ALPL gene. One case (involving a neonate) exhibited respiratory insufficiency associated with vitamin B6 dependent convulsions, significant defective mineralization similar to the severe form of HPP, and extremely low ALP activity. Enzyme replacement therapy (ERT) using asfotase alfa promptly improved her respiratory insufficiency, bone mineralization, and maintained her motor development during infancy. The second case involved a 10-year-old boy who demonstrated diffuse musculoskeletal pain and weakness that progressively disturbed mobility. Although he showed no bony lesions, the clinical symptoms and biochemical abnormalities were compatible with childhood HPP. ERT successfully relieved the severe generalized pain and significantly improved motor function. |
| first_indexed | 2024-04-13T05:06:52Z |
| format | Article |
| id | doaj.art-f78e672c32c642a5a0fb2b749ea16077 |
| institution | Directory Open Access Journal |
| issn | 2352-1872 |
| language | English |
| last_indexed | 2024-04-13T05:06:52Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Bone Reports |
| spelling | doaj.art-f78e672c32c642a5a0fb2b749ea160772022-12-22T03:01:09ZengElsevierBone Reports2352-18722022-12-0117101626Two children with hypophosphatasia with a heterozygous c.1559delT variant in the ALPL gene, the most common variant in Japanese populationsHiroshi Kitoh0Masako Izawa1Hiroshi Kaneko2Akiko Kitamura3Saori Matsuyama4Kohji Kato5Tomoo Ogi6Department of Orthopaedic Surgery, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi 474-8710, Japan; Department of Comprehensive Pediatric Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan; Corresponding author at: Department of Orthopaedic Surgery, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi 474-8710, Japan.Department of Endocrinology and Metabolism, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi 474-8710, JapanDepartment of Orthopaedic Surgery, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi 474-8710, JapanDepartment of Orthopaedic Surgery, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi 474-8710, JapanDepartment of Orthopaedic Surgery, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi 474-8710, JapanDepartment of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8601, JapanDepartment of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8601, JapanHypophosphatasia (HPP), a genetic disorder characterized by decreased tissue-nonspecific alkaline phosphatase (TNSALP) activity, is caused by loss-of-function mutations in the ALPL gene, which encodes TNSALP. The most frequent pathogenic variant in Japanese patients with HPP is a frameshift mutation in the ALPL gene, c.1559delT, and its carrier frequency is reported to be one in 480 in the Japanese population. We report the cases of two Japanese children with HPP who had a heterozygous c.1559delT variant in the ALPL gene. One case (involving a neonate) exhibited respiratory insufficiency associated with vitamin B6 dependent convulsions, significant defective mineralization similar to the severe form of HPP, and extremely low ALP activity. Enzyme replacement therapy (ERT) using asfotase alfa promptly improved her respiratory insufficiency, bone mineralization, and maintained her motor development during infancy. The second case involved a 10-year-old boy who demonstrated diffuse musculoskeletal pain and weakness that progressively disturbed mobility. Although he showed no bony lesions, the clinical symptoms and biochemical abnormalities were compatible with childhood HPP. ERT successfully relieved the severe generalized pain and significantly improved motor function.http://www.sciencedirect.com/science/article/pii/S2352187222004600HypophosphatasiaAlkaline phosphataseALPL genec.1559delTEnzyme replacement therapy |
| spellingShingle | Hiroshi Kitoh Masako Izawa Hiroshi Kaneko Akiko Kitamura Saori Matsuyama Kohji Kato Tomoo Ogi Two children with hypophosphatasia with a heterozygous c.1559delT variant in the ALPL gene, the most common variant in Japanese populations Bone Reports Hypophosphatasia Alkaline phosphatase ALPL gene c.1559delT Enzyme replacement therapy |
| title | Two children with hypophosphatasia with a heterozygous c.1559delT variant in the ALPL gene, the most common variant in Japanese populations |
| title_full | Two children with hypophosphatasia with a heterozygous c.1559delT variant in the ALPL gene, the most common variant in Japanese populations |
| title_fullStr | Two children with hypophosphatasia with a heterozygous c.1559delT variant in the ALPL gene, the most common variant in Japanese populations |
| title_full_unstemmed | Two children with hypophosphatasia with a heterozygous c.1559delT variant in the ALPL gene, the most common variant in Japanese populations |
| title_short | Two children with hypophosphatasia with a heterozygous c.1559delT variant in the ALPL gene, the most common variant in Japanese populations |
| title_sort | two children with hypophosphatasia with a heterozygous c 1559delt variant in the alpl gene the most common variant in japanese populations |
| topic | Hypophosphatasia Alkaline phosphatase ALPL gene c.1559delT Enzyme replacement therapy |
| url | http://www.sciencedirect.com/science/article/pii/S2352187222004600 |
| work_keys_str_mv | AT hiroshikitoh twochildrenwithhypophosphatasiawithaheterozygousc1559deltvariantinthealplgenethemostcommonvariantinjapanesepopulations AT masakoizawa twochildrenwithhypophosphatasiawithaheterozygousc1559deltvariantinthealplgenethemostcommonvariantinjapanesepopulations AT hiroshikaneko twochildrenwithhypophosphatasiawithaheterozygousc1559deltvariantinthealplgenethemostcommonvariantinjapanesepopulations AT akikokitamura twochildrenwithhypophosphatasiawithaheterozygousc1559deltvariantinthealplgenethemostcommonvariantinjapanesepopulations AT saorimatsuyama twochildrenwithhypophosphatasiawithaheterozygousc1559deltvariantinthealplgenethemostcommonvariantinjapanesepopulations AT kohjikato twochildrenwithhypophosphatasiawithaheterozygousc1559deltvariantinthealplgenethemostcommonvariantinjapanesepopulations AT tomooogi twochildrenwithhypophosphatasiawithaheterozygousc1559deltvariantinthealplgenethemostcommonvariantinjapanesepopulations |